Dimoveo Medical

Company Overview

Snapshot

Founded in July 2020 by Yaniv Lambaz, Dr. Tahel Altman, and Dr. Shlomo Rotter, Dimoveo Medical operates with 1–10 employees. The company has raised $800,000 across one funding round from one investor, with MEDX Xelerator participating as a lead investor. In October 2020, the company secured its seed funding.

Business overview

Dimoveo Medical specializes in developing advanced internal body cavity disinfection technologies for medical implants. The company's core technology utilizes ultrasound-accelerated nanoparticles to effectively clean implants without requiring their removal from the body, addressing a critical need in medical procedures. This innovative approach allows for the disinfection of areas previously inaccessible, serving the healthcare and life sciences sectors, particularly within medical devices and treatment therapeutics.

Strategic signal

In October 2020, Dimoveo Medical secured seed funding from MEDX Xelerator, signaling early validation for its innovative approach to implant disinfection. This investment highlights investor confidence in the company's potential to disrupt traditional medical device maintenance and improve patient outcomes by offering a non-invasive cleaning solution for internal implants.

Company Intelligence Q&A

What is Dimoveo Medical's primary focus?

Dimoveo Medical focuses on developing internal body cavity disinfection technologies for medical implants that do not require the implants to be removed from the body.

When was Dimoveo Medical founded?

Dimoveo Medical was founded in July 2020.

Which investors participated in Dimoveo Medical's funding round?

In October 2020, Dimoveo Medical secured $800,000 in seed funding from.

What is the core technology used by Dimoveo Medical?

Dimoveo Medical's technology utilizes ultrasound-accelerated nanoparticles to strike implants at high velocity, enabling effective cleaning and disinfection.

What problem does Dimoveo Medical's technology address?

The technology addresses the challenge of disinfecting medical implants in areas that previously required the implant to be replaced, by providing a non-invasive cleaning process.